PRPO logo.png
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
September 26, 2019 10:53 ET | Precipio, Inc.
 Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO),...
PRPO logo.png
Precipio Pathology Sales Metrics Demonstrate Continuous Improvement in Q2 2019
August 13, 2019 11:30 ET | Precipio, Inc.
NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the results of three key performance metrics that together...
zomedica-horizontal-tag.jpg
Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4
July 25, 2019 06:55 ET | Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., July 25, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced Dr. Bonnie...
PRPO logo.png
Precipio and H3 Biomedicine Sign Second Development Agreement
June 25, 2019 09:15 ET | Precipio, Inc.
NEW HAVEN, Conn., June 25, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced the initiation of a second development project with H3 Biomedicine that...
PRPO logo.png
Precipio CEO Provides Update Letter To Shareholders
June 17, 2019 10:39 ET | Precipio, Inc.
NEW HAVEN, Conn., June 17, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), provides an update to its shareholders. Dear Investors: We are all aware of the...
zomedica-horizontal-tag.jpg
Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform
June 13, 2019 06:55 ET | Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 13, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it has...
PRPO logo.png
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
June 04, 2019 09:10 ET | Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
PRPO logo.png
Precipio CEO enrolls in long term stock purchase plan
May 23, 2019 09:55 ET | Precipio, Inc.
NEW HAVEN, Conn., May 23, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that, as previously stated, Ilan Danieli, Precipio’s CEO, has enrolled...
RND logo.PNG
DNA and Gene Chip Market To Reach USD 11.25 Billion by 2026 | Reports And Data
May 22, 2019 12:52 ET | Reports And Data
High prevalence of Cancer, technical knowledge about gene expression, need for sustainable agricultural yields, increasing strategic developments such as collaborative studies, favorable research...
Inspirata Introduces Artificial Intelligence Tool-Sets to their Digital Pathology Solution at Pathology Informatics Summit
May 06, 2019 07:50 ET | Inspirata, Inc.
Pittsburgh, Pennsylvania, May 06, 2019 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata today revealed their strategy to bring two new artificial...